Aptevo Therapeutics Inc (APVO)

May 12, 2025

Aptevo Therapeutics (APVO) Expected to Announce Earnings on Wednesday - Defense World

May 12, 2025

May 10, 2025

Aptevo Therapeutics (NASDAQ:APVO) Now Covered by Analysts at StockNews.com - Defense World

May 10, 2025

May 08, 2025

Aptevo Therapeutics Announces $3.0 Million Offering Priced At-the-Market Under Nasdaq Rules - ACCESS Newswire

May 08, 2025

May 08, 2025

Aptevo Therapeutics Provides Program Update for Bispecific APVO7 - GuruFocus

May 08, 2025

May 08, 2025

Aptevo Therapeutics Says In Preclinical Studies APVO711 Demonstrates Dual Anti-Cancer Functionality - marketscreener.com

May 08, 2025

May 08, 2025

Aptevo Therapeutics (APVO) Advances Innovative Immunotherapy wit - GuruFocus

May 08, 2025

May 08, 2025

Aptevo Therapeutics (APVO) Advances Innovative Immunotherapy with APVO711 Update | APVO Stock News - GuruFocus

May 08, 2025

May 08, 2025

Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation | APVO Stock News - GuruFocus

May 08, 2025

May 08, 2025

Aptevo Therapeutics Provides Program Update for Bispecific APVO711, a PD-L1 X CD40 that Combines a Checkpoint Inhibitor and Immune Activation - ACCESS Newswire

May 08, 2025

May 01, 2025

Aptevo Therapeutics announces common stock offering - Investing.com Australia

May 01, 2025

Apr 30, 2025

APVO’s latest rating updates from top analysts. - knoxdaily.com

Apr 30, 2025

Apr 30, 2025

Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize

Apr 30, 2025

Apr 29, 2025

Aptevo Therapeutics announces common stock offering By Investing.com - Investing.com Canada

Apr 29, 2025

Apr 29, 2025

Closing Bell Recap: Aptevo Therapeutics Inc (APVO) Ends at 0.61, Reflecting a -9.31 Downturn - DWinneX

Apr 29, 2025

Apr 29, 2025

Aptevo Therapeutics announces at-the-market offering - Investing.com Australia

Apr 29, 2025

Apr 28, 2025

APVO stock plunges to 52-week low, touches $0.59 - Investing.com

Apr 28, 2025

Apr 28, 2025

APVO stock plunges to 52-week low, touches $0.59 By Investing.com - Investing.com UK

Apr 28, 2025

Apr 28, 2025

Aptevo Therapeutics announces at-the-market offering By Investing.com - Investing.com India

Apr 28, 2025

Apr 28, 2025

SEC Form 424B4 filed by Aptevo Therapeutics Inc. - Quantisnow

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 26, 2025

Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering - ACCESS Newswire

Apr 26, 2025

Apr 25, 2025

Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

Applied Materials Q2 Earnings: Tech Giant's Financial Results Coming May 15 - Stock Titan

Apr 25, 2025

Apr 24, 2025

A look into Aptevo Therapeutics Inc (APVO)’s deeper side - Sete News

Apr 24, 2025

Apr 23, 2025

Aptevo Therapeutics Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

Evogene (EVGN) Sees Dramatic Surge in Investor Interest Amid Strategic Moves | APVO Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Market Momentum: Aptevo Therapeutics Inc (APVO) Registers a 9.08 Increase, Closing at 0.69 - DWinneX

Apr 23, 2025

Apr 22, 2025

Aptevo Therapeutics Announces the Closing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Aptevo Therapeutics Raises Fresh Capital: $2M Direct Offering to Advance Cancer Drug Pipeline - Stock Titan

Apr 22, 2025

Apr 22, 2025

Aptevo Therapeutics Inc (APVO) Shares Are Down -85.25% YTD - Marketing Sentinel

Apr 22, 2025

Apr 22, 2025

Aptevo Therapeutics announces $2 million stock offering By Investing.com - Investing.com India

Apr 22, 2025

Apr 21, 2025

Aptevo Therapeutics $2.0 Million Registered Direct Offering Pric - GuruFocus

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics (APVO) Secures $2M Through Registered Direct Offering | APVO Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules | APVO Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics announces $2 million stock offering - Investing.com

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics Raises Fresh Capital: $2M Boost for Revolutionary Cancer Treatment Development - Stock Titan

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics Inc (APVO) Stock: Navigating a Year of Volatility - investchronicle.com

Apr 21, 2025

Apr 21, 2025

How does APVO’s price to cash per share ratio compare in the market? - uspostnews.com

Apr 21, 2025

Apr 21, 2025

Aptevo Therapeutics (APVO) Completes $2.1 Million Stock Offering - GuruFocus

Apr 21, 2025

Apr 21, 2025

Why Netflix Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 21, 2025

Apr 18, 2025

Now Is A Good Time To Buy Aptevo Therapeutics Inc (NASDAQ: APVO) - Marketing Sentinel

Apr 18, 2025

Apr 15, 2025

APVO stock plunges to 52-week low, touches $0.94 By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

APVO stock plunges to 52-week low, touches $0.94 - Investing.com Australia

Apr 15, 2025

Apr 10, 2025

Alligator Bioscience and Aptevo Therapeutics to Present Positive Interim Phase 1 Data Evaluating ALG.APV-527 Monotherapy in Multiple Solid Tumor Types at ESMO Congress 2024 - ACCESS Newswire

Apr 10, 2025

Apr 06, 2025

Aptevo Stock Rises On $2.1M Registered Direct Offering, Warrant Sale: Retail Sentiment Touches Year-High - Asianet Newsable

Apr 06, 2025